At today’s
#ESMO2023
conference, Balma Gil, our BDD attended the poster presentation given by Dr. Thomas M Enzler, MD, PhD, on the results from a Phase 2 pancreatic cancer study.
We take great pride in being a part of this significant achievement in this ongoing battle.
Veristat is delighted to share the findings from a Phase 2 clinical trial for pancreatic cancer will be unveiled at the
#ESMO23
congress on 23 October.
Find out more and join us >